Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMC 2888745)

Published in BMC Public Health on May 28, 2010


Edith A M Tarimo1, Anna Thorson, Thecla W Kohi, Joachim Mwami, Muhammad Bakari, Eric Sandström, Asli Kulane

Author Affiliations

1: Division of Global Health, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.

Articles cited by this

Defining and refining international donor support for combating the AIDS pandemic. Lancet (2001) 5.05

Factors affecting African-American participation in AIDS research. J Acquir Immune Defic Syndr (2000) 2.96

Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. J Acquir Immune Defic Syndr (2004) 2.39

HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment. J Acquir Immune Defic Syndr (2006) 2.35

Motivations for participating in an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr (2005) 2.04

Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial. J Acquir Immune Defic Syndr (2002) 2.02

Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US. Int J STD AIDS (2006) 2.02

A pilot study on willingness to participate in future preventive HIV vaccine trials. Indian J Med Res (2006) 1.85

Knowledge and attitudes towards HIV vaccines among Soweto adolescents. BMC Res Notes (2008) 1.72

Motherhood in sub-Saharan Africa: the social consequences of infertility in an urban population in northern Tanzania. Cult Health Sex (2008) 1.61

The value of children in African countries: insights from studies on infertility. J Psychosom Obstet Gynaecol (2007) 1.60

HIV vaccine acceptability among women at risk: perceived barriers and facilitators to future HIV vaccine uptake. AIDS Educ Prev (2005) 1.47

Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities. J Acquir Immune Defic Syndr (2001) 1.43

Why blacks do not take part in HIV vaccine trials. J Natl Med Assoc (2007) 1.40

Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda. J Acquir Immune Defic Syndr (2004) 1.40

Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda. Trop Med Int Health (2009) 1.39

Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers. Vaccine (2005) 1.36

Public engagement with science? Local understandings of a vaccine trial in the Gambia. J Biosoc Sci (2005) 1.31

HIV vaccine trial preparedness among Spanish-speaking Latinos in the US. AIDS Care (2007) 1.31

The prevalence and incidence of HIV-1 infection and syphilis in a cohort of police officers in Dar es Salaam, Tanzania: a potential population for HIV vaccine trials. AIDS (2000) 1.20

Strengths and challenges in the use of interpretive description: reflections arising from a study of the moral experience of health professionals in humanitarian work. Qual Health Res (2009) 1.16

Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. J Acquir Immune Defic Syndr (2001) 1.16

Perceptions of a community sample about participation in future HIV vaccine trials in south India. AIDS Behav (2006) 1.16

Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India. AIDS Res Hum Retroviruses (2009) 1.08

Local understanding of an HIV vaccine and its relationship with HIV-related stigma in the Dominican Republic. AIDS Care (2007) 1.07

Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey. AIDS Care (2006) 1.07

Willingness of Chinese injection drug users to participate in HIV vaccine trials. Vaccine (2007) 1.06

First trial of the HIV-1 vaccine in Africa: Ugandan experience. BMJ (2002) 1.06

HIV vaccine knowledge and beliefs among communities at elevated risk: conspiracies, questions and confusion. J Natl Med Assoc (2005) 1.05

HIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries. AIDS Care (2007) 1.00

Preparedness for AIDS vaccine trials in India. Indian J Med Res (2008) 0.97

Willingness to volunteer in a Phase I/II HIV vaccine trial: a study among police officers in Dar es Salaam, Tanzania. Glob Health Action (2009) 0.94

Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia. Int J STD AIDS (2005) 0.93

Local knowledge and experiences of vaccination: implications for HIV-preventive vaccine trials in South Africa. Health Educ Behav (2006) 0.91

Pediatric HIV type 1 vaccine trial acceptability among mothers in Kenya. AIDS Res Hum Retroviruses (2006) 0.90

Articles by these authors

High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis (2005) 4.45

Improved response to disasters and outbreaks by tracking population movements with mobile phone network data: a post-earthquake geospatial study in Haiti. PLoS Med (2011) 4.38

Rate of decline of absolute number and percentage of CD4 T lymphocytes among HIV-1-infected adults in Dar es Salaam, Tanzania. AIDS (2004) 2.45

Challenges for scaling up ART in a resource-limited setting: a retrospective study in Kibera, Kenya. J Acquir Immune Defic Syndr (2009) 2.37

Disclosure of HIV status: experiences and perceptions of persons living with HIV/AIDS and nurses involved in their care in Africa. Qual Health Res (2008) 2.25

Validation of the HIV/AIDS Stigma Instrument - PLWA (HASI-P). AIDS Care (2007) 2.14

A conceptual model of HIV/AIDS stigma from five African countries. J Adv Nurs (2007) 1.98

My partner wants a child: a cross-sectional study of the determinants of the desire for children among mutually disclosed sero-discordant couples receiving care in Uganda. BMC Public Health (2010) 1.93

Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort study. PLoS One (2010) 1.79

Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara. J Infect Dis (2008) 1.77

Coping with HIV-related stigma in five African countries. J Assoc Nurses AIDS Care (2008) 1.77

Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine. AIDS (2010) 1.76

The dilemma of safe sex and having children: challenges facing HIV sero-discordant couples in Uganda. Afr Health Sci (2009) 1.72

Why give birth in health facility? Users' and providers' accounts of poor quality of birth care in Tanzania. BMC Health Serv Res (2013) 1.68

HIV stigma and missed medications in HIV-positive people in five African countries. AIDS Patient Care STDS (2009) 1.62

Verbal and physical abuse and neglect as manifestations of HIV/AIDS stigma in five African countries. Public Health Nurs (2007) 1.55

"It is not that I forget, it's just that I don't want other people to know": barriers to and strategies for adherence to antiretroviral therapy among HIV patients in Northern Vietnam. AIDS Care (2011) 1.43

Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania. Vaccine (2011) 1.37

Opt-out HIV testing during antenatal care: experiences of pregnant women in rural Uganda. Health Policy Plan (2011) 1.35

Ethnic minority health in Vietnam: a review exposing horizontal inequity. Glob Health Action (2013) 1.34

Perceived HIV stigma and life satisfaction among persons living with HIV infection in five African countries: a longitudinal study. Int J Nurs Stud (2009) 1.33

The impact of taking or not taking ARVs on HIV stigma as reported by persons living with HIV infection in five African countries. AIDS Care (2009) 1.30

Effect of home based HIV counselling and testing intervention in rural South Africa: cluster randomised trial. BMJ (2013) 1.30

Test characteristics of urinary lipoarabinomannan and predictors of mortality among hospitalized HIV-infected tuberculosis suspects in Tanzania. PLoS One (2012) 1.26

To use or not to use a condom: a prospective cohort study comparing contraceptive practices among HIV-infected and HIV-negative youth in Uganda. BMC Infect Dis (2011) 1.26

HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J Med Virol (2003) 1.25

Power imbalance and consumerism in the doctor-patient relationship: health care providers' experiences of patient encounters in a rural district in India. Qual Health Res (2006) 1.25

Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J Med Virol (2005) 1.24

Mistrust in marriage--reasons why men do not accept couple HIV testing during antenatal care- a qualitative study in eastern Uganda. BMC Public Health (2010) 1.23

Knowledge and attitude on maternal health care among rural-to-urban migrant women in Shanghai, China. BMC Womens Health (2009) 1.19

The development and validation of the HIV/AIDS Stigma Instrument - Nurse (HASI-N). AIDS Care (2009) 1.17

Waiting for attention and care: birthing accounts of women in rural Tanzania who developed obstetric fistula as an outcome of labour. BMC Pregnancy Childbirth (2011) 1.17

Knowledge, attitudes, and practices about tuberculosis and choice of communication channels in a rural community in Vietnam. Health Policy (2008) 1.15

Voices on adherence to ART in Ethiopia and Uganda: a matter of choice or simply not an option? AIDS Care (2009) 1.15

Measuring HIV stigma for PLHAs and nurses over time in five African countries. SAHARA J (2009) 1.14

HIV-1 transmission cluster with M41L 'singleton' mutation and decreased transmission of resistance in newly diagnosed Swedish homosexual men. Antivir Ther (2006) 1.14

Sputum microscopy for the diagnosis of HIV-associated pulmonary tuberculosis in Tanzania. BMC Public Health (2008) 1.14

Implementation of web-based respondent-driven sampling among men who have sex with men in Vietnam. PLoS One (2012) 1.11

"I am nothing": experiences of loss among women suffering from severe birth injuries in Tanzania. BMC Womens Health (2011) 1.11

Gender roles and informal care for patients with AIDS: a qualitative study from an urban area in Tanzania. J Transcult Nurs (2008) 1.11

Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2002) 1.11

Peer support and improved quality of life among persons living with HIV on antiretroviral treatment: a randomised controlled trial from north-eastern Vietnam. Health Qual Life Outcomes (2012) 1.10

The bacteraemia of disseminated tuberculosis among HIV-infected patients with prolonged fever in Tanzania. Scand J Infect Dis (2011) 1.07

Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam. Scand J Infect Dis (2011) 1.06

Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health (2008) 1.05

The evolution of HIV policy in Vietnam: from punitive control measures to a more rights-based approach. Glob Health Action (2010) 1.05

Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity. Vaccine (2009) 1.05

Sexual risk taking among patients on antiretroviral therapy in an urban informal settlement in Kenya: a cross-sectional survey. J Int AIDS Soc (2011) 1.04

Social networks and concurrent sexual relationships--a qualitative study among men in an urban South African community. AIDS Care (2009) 1.04

Expanding HIV testing efforts in concentrated epidemic settings: a population-based survey from rural Vietnam. PLoS One (2011) 1.04

A new multi-clade DNA prime/recombinant MVA boost vaccine induces broad and high levels of HIV-1-specific CD8(+) T-cell and humoral responses in mice. Mol Ther (2007) 1.03

Challenges to ART scale-up in a rural district in Tanzania: stigma and distrust among Tanzanian health care workers, people living with HIV and community members. Trop Med Int Health (2010) 1.01

Tuberculosis in HIV voluntary counselling and testing centres in Dar es Salaam, Tanzania. Scand J Infect Dis (2010) 1.01

"Money talks, bullshit walks" interrogating notions of consumption and survival sex among young women engaging in transactional sex in post-apartheid South Africa: a qualitative enquiry. Global Health (2013) 1.01

HIV stigma and nurse job satisfaction in five African countries. J Assoc Nurses AIDS Care (2009) 1.01

Low uptake of HIV testing during antenatal care: a population-based study from eastern Uganda. AIDS (2009) 1.01

Community patterns of stigma towards persons living with HIV: a population-based latent class analysis from rural Vietnam. BMC Public Health (2011) 1.01

Provider experiences of the implementation of a new tuberculosis treatment programme: a qualitative study using the normalisation process model. BMC Health Serv Res (2011) 1.00

Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis. J Infect Dis (2010) 1.00

Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania. Vaccine (2010) 0.99

The perceptions on male circumcision as a preventive measure against HIV infection and considerations in scaling up of the services: a qualitative study among police officers in Dar es Salaam, Tanzania. BMC Public Health (2012) 0.99

"Not a boy, not a child": A qualitative study on young people's views on childbearing in Uganda. Afr J Reprod Health (2010) 0.99

"Taking care of business": alcohol as currency in transactional sexual relationships among players in Cape Town, South Africa. Qual Health Res (2010) 0.98

Predictors of inconsistent condom use among a hard to reach population of young women with multiple sexual partners in peri-urban South Africa. PLoS One (2012) 0.98

Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA. Vaccine (2004) 0.97

Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in Tanzania. PLoS One (2012) 0.97

Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation. Vaccine (2010) 0.96

Oral HIV-exposure elicits mucosal HIV-neutralizing antibodies in uninfected men who have sex with men. AIDS (2009) 0.95

Reasons for declining to enroll in a phase I and II HIV vaccine trial after randomization among eligible volunteers in Dar es Salaam, Tanzania. PLoS One (2011) 0.95

Trends and determinants of under-five mortality in Uganda. East Afr J Public Health (2009) 0.94

'Testing Together Challenges the Relationship': Consequences of HIV Testing as a Couple in a High HIV Prevalence Setting in Rural South Africa. PLoS One (2013) 0.94

Willingness to volunteer in a Phase I/II HIV vaccine trial: a study among police officers in Dar es Salaam, Tanzania. Glob Health Action (2009) 0.94

Strong HIV-specific CD4+ and CD8+ T-lymphocyte proliferative responses in healthy individuals immunized with an HIV-1 DNA vaccine and boosted with recombinant modified vaccinia virus ankara expressing HIV-1 genes. Clin Vaccine Immunol (2010) 0.94

Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania. Antivir Ther (2011) 0.94

Slow progression of HIV-1 infection in a cohort of antiretroviral naïve hotel workers in Dar es Salaam, Tanzania as defined by their CD4 cell slopes. Scand J Infect Dis (2008) 0.93

Effect of improved access to antiretroviral therapy on clinical characteristics of patients enrolled in the HIV care and treatment clinic, at Muhimbili National Hospital (MNH), Dar es Salaam, Tanzania. BMC Public Health (2010) 0.93

Global HIV surveillance among MSM: is risk behavior seriously underestimated? AIDS (2010) 0.92

A novel assay for assessment of HIV-specific cytotoxicity by multiparameter flow cytometry. Cytometry A (2005) 0.92

The construction of an idealised urban masculinity among men with concurrent sexual partners in a South African township. Glob Health Action (2010) 0.89

The two-year impact of first generation protease inhibitor based antiretroviral therapy (PI-ART) on health-related quality of life. Health Qual Life Outcomes (2005) 0.89

Antiretroviral treatment of HIV infection: Swedish recommendations 2007. Scand J Infect Dis (2007) 0.88

Molecular epidemiology of HIV-associated tuberculosis in Dar es Salaam, Tanzania: strain predominance, clustering, and polyclonal disease. J Clin Microbiol (2012) 0.88

Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis. BMC Infect Dis (2009) 0.87

A qualitative evaluation of volunteers' experiences in a phase I/II HIV vaccine trial in Tanzania. BMC Infect Dis (2011) 0.86

Health system capacity: maternal health policy implementation in the state of Gujarat, India. Glob Health Action (2013) 0.86

Polyantigenic interferon-γ responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization. PLoS One (2011) 0.86

Antiretroviral treatment of HIV in Uganda: a comparison of three different delivery models in a single hospital. Trans R Soc Trop Med Hyg (2007) 0.86


Antiretroviral treatment of HIV infection: Swedish recommendations 2005. Scand J Infect Dis (2006) 0.85

Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees. AIDS Res Hum Retroviruses (2013) 0.85